Stem Cell treatment in Diabetes
Diabetes management may benefit from stem cell therapy. In order to replace damaged or defective cells in diabetic patients, researchers are investigating the capacity of stem cells to develop into cells that produce insulin. The regenerative potential of many stem cell types, such as adult stem cells, induced pluripotent stem cells, and embryonic stem cells, is being investigated. Early clinical trials have produced good outcomes in terms of enhancing insulin production and glycaemic management. Before stem cell-based therapies for diabetes may be extensively used in clinical practise, additional study is required to confirm their safety, long-term efficacy, and scalability.
Related Conference of Stem Cell treatment in Diabetes
September 23-24, 2026
24th Global Conference on Diabetes, Endocrinology and Primary Healthcare
Paris, France
September 28-29, 2026
25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders
Berlin, Germany
November 23-24, 2026
35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment
Amsterdam, Netherlands